{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:25:32Z","timestamp":1694636732907},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/pai.0b013e31818a9d90","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T07:20:04Z","timestamp":1245309604000},"page":"351-356","source":"Crossref","is-referenced-by-count":1,"title":["Expression of Galectin-3, CD138, p16INK4a, and TTF-1 in Mucinous Bronchioloalveolar Adenocarcinoma After Hodgkin Lymphoma"],"prefix":"10.1097","volume":"17","author":[{"given":"Suhail","family":"Al-Salam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moueid","family":"Al-Ashari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.5858\/2007-131-1027-BCAROC","article-title":"Bronchioloalveolar carcinoma: a review of current concepts and evolving issues","volume":"131","author":"Yousem","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R2-13-20210126","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ejca.2007.01.023","article-title":"Children's Cancer and Leukaemia Group. Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial","volume":"43","author":"Capra","year":"2007","journal-title":"Eur J Cancer"},{"key":"R3-13-20210126","first-page":"37","article-title":"Radiation-induced lung injury. Assessment, management, and prevention","volume":"22","author":"Ghafoori","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"R4-13-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11604-007-0165-z","article-title":"Experimental stereotactic irradiation of normal rabbit lung: computed tomographic analysis of radiation injury and the histopathological features","volume":"25","author":"Kawase","year":"2007","journal-title":"Radiat Med"},{"key":"R5-13-20210126","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2007.10.044","article-title":"Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study","volume":"85","author":"Guckenberger","year":"2007","journal-title":"Radiother Oncol"},{"key":"R6-13-20210126","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ijrobp.2007.08.050","article-title":"Pulmonary changes after radiotherapy for conservative treatment of breast cancer: a prospective study","volume":"70","author":"Krengli","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-13-20210126","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1200\/JCO.2005.04.2200","article-title":"Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study","volume":"24","author":"Mudie","year":"2006","journal-title":"J Clin Oncol"},{"key":"R8-13-20210126","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nrc1749","article-title":"Mechanisms of therapy-related carcinogenesis","volume":"5","author":"Allan","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R9-13-20210126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","article-title":"Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease","volume":"94","author":"Travis","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R10-13-20210126","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","article-title":"Second malignancies after breast cancer: the impact of different treatment modalities","volume":"98","author":"Sachs","year":"2008","journal-title":"Br J Cancer"},{"key":"R11-13-20210126","doi-asserted-by":"crossref","first-page":"13040","DOI":"10.1073\/pnas.0506648102","article-title":"Solid tumor risks after high doses of ionizing radiation","volume":"102","author":"Sachs","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-13-20210126","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2007.13.3033","article-title":"Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer","volume":"26","author":"Kaufman","year":"2008","journal-title":"J Clin Oncol"},{"key":"R13-13-20210126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jtbi.2007.07.034","article-title":"Second cancers after fractionated radiotherapy: stochastic population dynamics effects","volume":"249","author":"Sachs","year":"2007","journal-title":"J Theor Biol"},{"key":"R14-13-20210126","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.23081","article-title":"Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma","volume":"110","author":"Hodgson","year":"2007","journal-title":"Cancer"},{"key":"R15-13-20210126","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.bjc.6602731","article-title":"Second primary malignancies after treatment for malignant lymphoma","volume":"93","author":"Okines","year":"2005","journal-title":"Br J Cancer"},{"key":"R16-13-20210126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.lungcan.2007.09.001","article-title":"Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: long-term follow-up of radiological findings","volume":"60","author":"Soda","year":"2008","journal-title":"Lung Cancer"},{"key":"R17-13-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1309\/CM20WA20RW3T600L","article-title":"Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens","volume":"121","author":"Simsir","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R18-13-20210126","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00432-007-0345-3","article-title":"Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study","volume":"134","author":"Abdel-Aziz","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"R19-13-20210126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.pai.0000213143.32030.f5","article-title":"Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach","volume":"15","author":"Papay","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R20-13-20210126","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/cncr.20542","article-title":"Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma","volume":"101","author":"Shah","year":"2004","journal-title":"Cancer"},{"key":"R21-13-20210126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/MCB.18.1.378","article-title":"p16INK4A participates in a G1 arrest checkpoint in response to DNA damage","volume":"18","author":"Shapiro","year":"1998","journal-title":"Mol Cell Biol"},{"key":"R22-13-20210126","first-page":"8","article-title":"Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line","volume":"61","author":"Tweddle","year":"2001","journal-title":"Cancer Res"},{"key":"R23-13-20210126","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","article-title":"p53 status and the efficacy of cancer therapy in vivo","volume":"266","author":"Lowe","year":"1994","journal-title":"Science"},{"key":"R24-13-20210126","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jnci\/87.20.1530","article-title":"Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease","volume":"87","author":"van Leeuwen","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R25-13-20210126","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1200\/JCO.2001.19.6.1610","article-title":"Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment","volume":"19","author":"Swerdlow","year":"2001","journal-title":"J Clin Oncol"},{"key":"R26-13-20210126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-2005-922035","article-title":"Secondary lung tumors in hematological patients","volume":"26","author":"Amadori","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"R27-13-20210126","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910520502","article-title":"Lung cancer following Hodgkin's disease: a case-control study","volume":"52","author":"Kaldor","year":"1992","journal-title":"Int J Cancer"}],"container-title":["Applied Immunohistochemistry & Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00129039-200907000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T14:35:07Z","timestamp":1633617307000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-200907000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0b013e31818a9d90","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}